Murphy Canyon Acquisition Corp. has entered into an Agreement and Plan of Merger with Conduit Pharmaceuticals Limited for its initial business combination, and has also entered into a Subscription Agreement with an accredited investor to purchase $27 million worth of units of the company's securities.